Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer
Irene Kuhn(Lawrence Berkeley National Laboratory), Terry Hermiston(Bayer (United States)), Steve H. Thorne(OSE Immunotherapeutics (France)), Richard N. Harkins(Bayer (United States)), Gabor M. Rubanyi(Bayer (United States)), Paul Harden(University of Oxford), Maxine Bauzon(Bayer (United States)), Kerry Fisher(Hybrid Instruments (United Kingdom)), Julie A. Nye(Bayer (United States)), Tony Reid(University of California San Diego), Cécile Chartier(Io Therapeutics (United States)), Shaoheng Ni(University of Washington Medical Center), André Lieber(University of Washington)
Cited by 212
Related Papers
Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli
|Journal of Virology|1996|651
Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
|Proceedings of the National Academy of Sciences|2012|630
Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
|PLoS ONE|2008|582
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials
|The Lancet|2020|445
Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma
|Journal of Clinical Oncology|2021|431